Cargando…
Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450221/ https://www.ncbi.nlm.nih.gov/pubmed/32889479 http://dx.doi.org/10.1016/j.ajp.2020.102377 |
| _version_ | 1783574772348616704 |
|---|---|
| author | Ghosh, Abhishek Singh, Shubhmohan Dutta, Anirban |
| author_facet | Ghosh, Abhishek Singh, Shubhmohan Dutta, Anirban |
| author_sort | Ghosh, Abhishek |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7450221 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74502212020-08-27 Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context Ghosh, Abhishek Singh, Shubhmohan Dutta, Anirban Asian J Psychiatr Letter to the Editor Published by Elsevier B.V. 2020-10 2020-08-27 /pmc/articles/PMC7450221/ /pubmed/32889479 http://dx.doi.org/10.1016/j.ajp.2020.102377 Text en © 2020 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ghosh, Abhishek Singh, Shubhmohan Dutta, Anirban Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context |
| title | Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context |
| title_full | Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context |
| title_fullStr | Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context |
| title_full_unstemmed | Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context |
| title_short | Opioid agonist treatment during SARS-CoV2 & extended lockdown: Adaptations & challenges in the Indian context |
| title_sort | opioid agonist treatment during sars-cov2 & extended lockdown: adaptations & challenges in the indian context |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450221/ https://www.ncbi.nlm.nih.gov/pubmed/32889479 http://dx.doi.org/10.1016/j.ajp.2020.102377 |
| work_keys_str_mv | AT ghoshabhishek opioidagonisttreatmentduringsarscov2extendedlockdownadaptationschallengesintheindiancontext AT singhshubhmohan opioidagonisttreatmentduringsarscov2extendedlockdownadaptationschallengesintheindiancontext AT duttaanirban opioidagonisttreatmentduringsarscov2extendedlockdownadaptationschallengesintheindiancontext |